ArticleCureus2026
Extracompartmental Two-Injection Technique for Treating De Quervain Tenosynovitis.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In this study, we prospectively analyzed patients diagnosed with and treated for De Quervain tenosynovitis (DQT) to evaluate the efficacy of a novel extracompartmental two-injection technique. Fifteen patients completed a Visual Analog Scale for pain, grip strength testing, and physical examination before receiving injections. After four weeks, these same measurements were repeated and compared to baseline. Statistical analysis was conducted using two-tailed t-tests to compare symptoms before and four weeks after treatment, pain associated with each injection, and grip strength before and four weeks after treatment. Results suggest that the extracompartmental two-injection technique led to significant symptom improvement and absent physical exam findings in 100% of patients, complete symptom resolution in 73% of patients, and improved grip strength in 93% of patients with DQT. We describe this reproducible technique to help providers and patients avoid the pain and risks associated with intracompartmental steroid injection while still achieving short-term outcomes comparable to those reported with other injection techniques.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.